552 related articles for article (PubMed ID: 7001096)
1. Anti-HLA-A, B, C and DR antibodies in renal transplant recipients.
Akiyama N; Kusaba R; Osawa N; Inou T; Kawamura A
Jpn J Exp Med; 1980 Jun; 50(3):205-11. PubMed ID: 7001096
[TBL] [Abstract][Full Text] [Related]
2. Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome.
Worthington JE; Martin S; Al-Husseini DM; Dyer PA; Johnson RW
Transplantation; 2003 Apr; 75(7):1034-40. PubMed ID: 12698094
[TBL] [Abstract][Full Text] [Related]
3. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
Lee PC; Ozawa M
Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
[TBL] [Abstract][Full Text] [Related]
4. Detection and analysis of HLA class I and class II specific alloantibodies in the sera of dialysis recipients waiting for a renal retransplantation.
Barocci S; Valente U; Nocera A
Clin Transplant; 2007; 21(1):47-56. PubMed ID: 17302591
[TBL] [Abstract][Full Text] [Related]
5. Screening of HLA-A, -B, -C and HLA-DR seric antibodies in blood donor married women. II. Study of two particular aspects of the HLA-DR immunization.
Diotallevi P
Boll Soc Ital Biol Sper; 1982 Jul; 58(14):925-8. PubMed ID: 6957203
[TBL] [Abstract][Full Text] [Related]
6. HLA-A, -B, and -DR matching and preoperative transfusions in renal transplantation.
Reinitz ER; Rhodes C; Ellis T; Goldman MH; Bacquero A; Mendez-Picon G; Lee HM; Carter WH; Mohanakumar T
Transplant Proc; 1984 Dec; 16(6):1415-8. PubMed ID: 6390840
[No Abstract] [Full Text] [Related]
7. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens.
Dignan R; O'Brien M; Hogan P; Thornton A; Fowler K; Byrne D; Stephens F; Harrocks S
J Heart Valve Dis; 2003 May; 12(3):382-90; discussion 390-1. PubMed ID: 12803340
[TBL] [Abstract][Full Text] [Related]
8. Good kidney transplant outcome in recipients with presensitization against HLA class II but not HLA class I.
Süsal C; Opelz G
Hum Immunol; 2004 Aug; 65(8):810-6. PubMed ID: 15336782
[TBL] [Abstract][Full Text] [Related]
9. Characterization of B-cell and monocyte antibodies in recipient sera and in eluates from rejected kidney allografts.
Nunez G; McPhaul J; Stastny P
Transplant Proc; 1981 Mar; 13(1 Pt 1):111-3. PubMed ID: 7022807
[TBL] [Abstract][Full Text] [Related]
10. Immunological profile of patients awaiting a renal transplant.
Díaz I; Sánchez P; Alonso C; Valdés F
Clin Transplant; 2004 Oct; 18(5):529-35. PubMed ID: 15344955
[TBL] [Abstract][Full Text] [Related]
11. Specific inhibition of HLA class I and II antibodies by soluble antigens--a method for the identification of antibody specificity in sera from alloimmunized individuals.
Sumitran-Karuppan S; Möller E
Transplantation; 1994 Sep; 58(6):713-9. PubMed ID: 7940692
[TBL] [Abstract][Full Text] [Related]
12. Dilutions and specificity analysis of pretransplant sera.
Iwaki Y; Terasaki PI; Park MS; Heintz R; Silberman H; Berne T
Transplant Proc; 1979 Mar; 11(1):944-9. PubMed ID: 377726
[TBL] [Abstract][Full Text] [Related]
13. Humoral immunity in renal transplantation Detection of cytotoxic antibodies to lymphocyte antigens other than HLA-A,B,C and Ia-like antigens in patients with vascular graft rejection.
Lordon RE; Wilson RL; Shield CF; Ferrone S
Transplantation; 1981 Oct; 32(4):286-90. PubMed ID: 7036445
[TBL] [Abstract][Full Text] [Related]
14. Post transplant development of MICA and anti-HLA antibodies is associated with acute rejection episodes and renal allograft loss.
Panigrahi A; Gupta N; Siddiqui JA; Margoob A; Bhowmik D; Guleria S; Mehra NK
Hum Immunol; 2007 May; 68(5):362-7. PubMed ID: 17462503
[TBL] [Abstract][Full Text] [Related]
15. Association between long-term kidney graft survival and the presence of pre-transplant cytotoxic anti-HLA and/or non-MHC 'Fc gamma RII blocking' (anti-TLX) alloantibody.
Padányi A; Gyódi E; Rajczy K; Perner F; Petrányi GG
Clin Transplant; 1996 Oct; 10(5):455-60. PubMed ID: 8930462
[TBL] [Abstract][Full Text] [Related]
16. [Kinetics of serum soluble HLA-A, B and DR antigens on human renal allografts].
Shiramizu T
Fukuoka Igaku Zasshi; 1983 Dec; 74(12):787-95. PubMed ID: 6373538
[No Abstract] [Full Text] [Related]
17. [Immunological selection of donors and recipients in renal grafts: antibodies].
Seignalet J; Mourad G; Mion C
Nephrologie; 1984; 5(1):33-9. PubMed ID: 6374486
[TBL] [Abstract][Full Text] [Related]
18. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
Herzberg GZ; Rossi AF; Courtney M; Gelb BD
J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
[TBL] [Abstract][Full Text] [Related]
19. Unexpected anti-HLA-DR and -DQ alloantibodies after nephrectomy of an HLA-DR and -DQ identical first renal transplant.
Proust B; Kennel A; Ladrière M; Kessler M; Perrier P
Transpl Immunol; 2009 Jul; 21(3):166-8. PubMed ID: 19341797
[TBL] [Abstract][Full Text] [Related]
20. Presensitized kidney graft recipients with HLA class I and II antibodies are at increased risk for graft failure: a Collaborative Transplant Study report.
Süsal C; Döhler B; Opelz G
Hum Immunol; 2009 Aug; 70(8):569-73. PubMed ID: 19375472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
